文献速递主动脉疾病

胸主动脉腔内修复术治疗伴溃疡样突起的急性B型壁内血肿可促进逆行主动脉弓扩展的重塑

Thoracic Endovascular Aortic Repair for the Management of Acute Type B Intramural Hematoma with Ulcer-like Projection Results in Remodeling of Concomitant Retrograde Arch Extension.
PubMed 文献 · Ann Vasc Surg · 2026-06-22

单中心回顾性研究纳入2018至2024年7例B型主动脉壁内血肿伴溃疡样突起及逆行A型壁内血肿扩展并接受TEVAR的患者,5例逆行A型壁内血肿在5个月内消退(其中2例早至3-5周),5例B型壁内血肿在10个月内消退(其中2例早至11-14天),1例失访。结论认为早期TEVAR可促进有利的主动脉重塑,无需开放升主动脉修复。

要点

  • B型壁内血肿伴溃疡样突起及逆行A型扩展者,早期TEVAR可促进主动脉重塑。
  • 逆行A型壁内血肿可在5个月内消退,部分早至3-5周。
  • B型壁内血肿成分可在10个月内消退,部分早至11-14天。

核心结论

  • 对B型壁内血肿伴溃疡样突起及逆行升主动脉或弓部壁内血肿扩展的患者,早期TEVAR可促进有利的主动脉重塑,无需开放升主动脉修复。

研究设计与样本

  • 单中心回顾性研究,经机构审查委员会批准并豁免知情同意,纳入2018至2024年接受TEVAR的B型壁内血肿伴降主动脉溃疡样突起及逆行A型壁内血肿扩展患者7例。

主要发现

  • 7例患者中5例逆行A型壁内血肿在5个月内消退,其中2例早至3-5周。
  • B型壁内血肿成分在5例患者中于10个月内消退,其中2例早至11-14天。
  • 7例患者中1例失访。

临床怎么用

  • 对于B型壁内血肿伴溃疡样突起及逆行A型壁内血肿扩展的患者,可考虑早期TEVAR以促进主动脉重塑并避免开放升主动脉修复。

局限性

  • 单中心回顾性研究,样本量仅7例,1例失访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aortic intramural hematoma (IMH) has an unpredictable clinical course depending on the extent of disease. Management remains unclear for patients with type B IMH with concomitant type A IMH. We examine our experience with thoracic endovascular aortic repair (TEVAR) for this patient subset. METHODS: The study design and research was approved by our institutional review board and the need for informed consent was waived. This is a single-institution retrospective study of patients with type B IMH with an ulcer-like projection (ULP) in the descending thoracic aorta, as well as retrograde type A IMH, who underwent TEVAR between 2018 and 2024. IMH thickness and extent was examined on computed tomography angiography imaging to assess for resolution and positive aortic remodeling after TEVAR. RESULTS: We identified 65 patients between 2018 and 2024 treated at our institution for IMH. Of those, 7 patients had a type B IMH with ULP with concomitant retrograde arch extension of the IMH, treated with TEVAR. In our series, 5 patients had resolution of the retrograde type A IMH by 5 months, and as early as 3-5 weeks in 2 of those patients. The type B component of IMH had resolved in 5 patients by 10 months and as early as 11-14 days in 2 patients. One of the 7 patients was lost to follow-up. CONCLUSION: Early TEVAR for patients with type B IMH, with ULP with concomitant retrograde ascending aortic or arch IMH, is a management strategy that can promote favorable aortic remodeling without the need for open ascending aortic repair.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. McIntosh E, Mustansir F, Wahidi R, et al. Thoracic Endovascular Aortic Repair for the Management of Acute Type B Intramural Hematoma with Ulcer-like Projection Results in Remodeling of Concomitant Retrograde Arch Extension. Ann Vasc Surg. 2026. PMID: 42331220. doi:10.1016/j.avsg.2026.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。